Jaffe CA - Search Results

1

Androgen deprivation therapy for prostate cancer results in significant loss of bone density.

Wei JT, Gross M, Jaffe CA, Gravlin K, Lahaie M, Faerber GJ, Cooney KA. Wei JT, et al. Among authors: jaffe ca. Urology. 1999 Oct;54(4):607-11. doi: 10.1016/s0090-4295(99)00301-5. Urology. 1999. PMID: 10510915 Clinical Trial.

2

Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and body mass index: clinical correlates of prostate volume among Black men.

Sarma AV, Jaffe CA, Schottenfeld D, Dunn R, Montie JE, Cooney KA, Wei JT. Sarma AV, et al. Among authors: jaffe ca. Urology. 2002 Mar;59(3):362-7. doi: 10.1016/s0090-4295(01)01546-1. Urology. 2002. PMID: 11880071

3

Peak bone mass in young healthy men is correlated with the magnitude of endogenous growth hormone secretion.

Russell-Aulet M, Shapiro B, Jaffe CA, Gross MD, Barkan AL. Russell-Aulet M, et al. Among authors: jaffe ca. J Clin Endocrinol Metab. 1998 Oct;83(10):3463-8. doi: 10.1210/jcem.83.10.5176. J Clin Endocrinol Metab. 1998. PMID: 9768647

4

Relationship of serum sex-steroid hormones and prostate volume in African American men.

Joseph MA, Wei JT, Harlow SD, Cooney KA, Dunn RL, Jaffe CA, Montie JE, Schottenfeld D. Joseph MA, et al. Among authors: jaffe ca. Prostate. 2002 Dec 1;53(4):322-9. doi: 10.1002/pros.10154. Prostate. 2002. PMID: 12430143 Free article.

5

Treatment of acromegaly with dopamine agonists.

Jaffe CA, Barkan AL. Jaffe CA, et al. Endocrinol Metab Clin North Am. 1992 Sep;21(3):713-35. Endocrinol Metab Clin North Am. 1992. PMID: 1355728 Review.

6

Nocturnal augmentation of growth hormone (GH) secretion is preserved during repetitive bolus administration of GH-releasing hormone: potential involvement of endogenous somatostatin--a clinical research center study.

Jaffe CA, Turgeon DK, Friberg RD, Watkins PB, Barkan AL. Jaffe CA, et al. J Clin Endocrinol Metab. 1995 Nov;80(11):3321-6. doi: 10.1210/jcem.80.11.7593445. J Clin Endocrinol Metab. 1995. PMID: 7593445 Clinical Trial.

7

In vivo semiquantification of hypothalamic growth hormone-releasing hormone (GHRH) output in humans: evidence for relative GHRH deficiency in aging.

Russell-Aulet M, Jaffe CA, Demott-Friberg R, Barkan AL. Russell-Aulet M, et al. Among authors: jaffe ca. J Clin Endocrinol Metab. 1999 Oct;84(10):3490-7. doi: 10.1210/jcem.84.10.6063. J Clin Endocrinol Metab. 1999. PMID: 10522985

8

Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation.

Pandya N, DeMott-Friberg R, Bowers CY, Barkan AL, Jaffe CA. Pandya N, et al. Among authors: jaffe ca. J Clin Endocrinol Metab. 1998 Apr;83(4):1186-9. doi: 10.1210/jcem.83.4.4711. J Clin Endocrinol Metab. 1998. PMID: 9543138 Clinical Trial.

9

Amiodarone-induced thyroid dysfunction.

Khanderia U, Jaffe CA, Theisen V. Khanderia U, et al. Among authors: jaffe ca. Clin Pharm. 1993 Oct;12(10):774-9. Clin Pharm. 1993. PMID: 8258259 Review.

10

Nocturnal growth hormone (GH) secretion is eliminated by infusion of GH-releasing hormone antagonist.

Ocampo-Lim B, Guo W, DeMott-Friberg R, Barkan AL, Jaffe CA. Ocampo-Lim B, et al. Among authors: jaffe ca. J Clin Endocrinol Metab. 1996 Dec;81(12):4396-9. doi: 10.1210/jcem.81.12.8954048. J Clin Endocrinol Metab. 1996. PMID: 8954048

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters